BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.110
+0.010 (0.92%)
May 6, 2026, 12:44 PM EDT - Market open
BioCardia Market Cap
BioCardia has a market cap or net worth of $12.14 million as of May 6, 2026. Its market cap has increased by 48.54% in one year.
Market Cap
12.14M
Enterprise Value
10.07M
1-Year Change
48.54%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $12.14M, a decrease of -58.23%. That is a compound annual growth rate of -8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 12.03M | -9.28% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 13.19M |
| BioVie | 12.67M |
| BioLineRx | 12.42M |
| Kairos Pharma | 12.14M |
| Lunai Bioworks | 11.60M |
| Chemomab Therapeutics | 11.58M |
| CytoMed Therapeutics | 11.52M |
| Cellectar Biosciences | 11.41M |